Intravitreal steroids have been widely used in the treatment of various ocular pathologies including macular edema and noninfectious uveitis.
Ozurdex (dexamethasone intravitreal implant 0.7 mg, Allergan) is delivered by a 22-gauge needle as an intravitreal implant. The FDA has authorized it as a first-line treatment for noninfectious uveitis affecting the posterior segment, diabetic macular edema and macular edema due to retinal vein blockage. There are case reports of complications such as migration of the implant, complicated cataract, glaucoma and accidental injection in the crystalline